Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01501877 · ClinicalTrials.gov registry record · NA

Smoking Cessation Intervention for Diabetic Patients

A NA study, sponsored by Rhode Island Hospital.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT01501877 is a NA study that has completed, run by Rhode Island Hospital. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01501877, a NA study, has completed, sponsored by Rhode Island Hospital.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

This study is designed to develop and test a smoking cessation intervention for smokers with Type 2 diabetes.

Interventions

  • BEHAVIORAL Acceptance and Commitment Therapy
  • BEHAVIORAL Standard smoking cessation intervention

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2011-12
Est. Completion 2016-06
Phase NA

Sponsor

Rhode Island Hospital

130 total trials

What the Registry Record Tells You About NCT01501877

The ClinicalTrials.gov registry entry for NCT01501877 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Acceptance and Commitment Therapy is the first listed.

NCT01501877 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01501877 about?

NCT01501877 is a clinical study titled "Smoking Cessation Intervention for Diabetic Patients". This study is designed to develop and test a smoking cessation intervention for smokers with Type 2 diabetes.

What is the current status of trial NCT01501877?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2011-12. Estimated completion is 2016-06.

What interventions are being tested in trial NCT01501877?

The interventions under investigation include: Acceptance and Commitment Therapy (BEHAVIORAL), Standard smoking cessation intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01501877?

This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.